The proportion of deaths was 6.37% in hospitals with a pharmacist-managed heparin programme and 7.19% in hospitals without this service, (p<0.0001).
The mean length of stay was 7.79 days (standard deviation, SD=9.41) in hospitals with a pharmacist-managed heparin programme versus 8.66 days (SD=11.17) in hospitals without this service, (p<0.0001).
A total of 8.84% of patients in hospitals with a pharmacist-managed heparin service experienced bleeding complications, compared with 9.12% in hospitals without such a service, (p<0.0009).
In hospitals with a pharmacist-managed heparin service, 13.82% of patients received a blood transfusion with a mean of 4.68 units (SD=7.77) being given, while in hospitals without such a service, 14.99% of patients received a mean of 5.90 units of blood (SD=22.40), (p<0.0001).
The proportion of deaths was 6.66% in hospitals with a pharmacist-managed warfarin programme and 7.10% in hospitals without this service, (p<0.0001).
The mean length of stay was 8.04 days (SD=9.60) in hospitals with a pharmacist-managed warfarin programme versus 8.54 days (SD=10.98) in hospitals without this service, (p<0.0001).
A total of 8.41% of patients in hospitals with a pharmacist-managed warfarin service experienced bleeding complications, compared with 9.15% in other hospitals, (p<0.0001).
In hospitals with a pharmacist-managed warfarin service 11.72% of patients received a blood transfusion with a mean of 4.89 units (SD=8.11) being given, while in hospitals without such a service, 15.12% of patients received a mean of 5.75 units of blood (SD=21.40), (p not significant).